Trial intelligence / Profile preview

FoamOtic Cipro vs Ciloxan in Acute Otitis Externa

NCT01157819Phase 2Completed

Sponsor
Otic Pharma
Start
Jul 2010
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of ciprofloxacin in acute otitis externa (AOE) (2 arms), sponsored by Otic Pharma. Primary endpoint: Clinical cure confirmed by significant reduction or absence of the disease symptoms at Day 14. Started Jul 2010; status: completed.

02

Drugs

ciprofloxacin
03

Conditions

acute otitis externa (AOE)

Beyond the preview

Go deeper on NCT01157819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01157819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call